About Salim Rezaie

Dr. Rezaie completed his medical school training at Texas A&M Health Science Center, and followed that up with a combined Emergency Medicine/Internal Medicine residency at East Carolina University in Greenville, NC. Currently, he is an attending on the faculty of UTHSCSA in San Antonio, TX, where he focuses on medical education, social media as a tool for education (FOAMed), and building the bridges between internal medicine, critical care, and emergency medicine. Feel free to contact him on Twitter (@srrezaie) (@UTHSCSAPearls) about anything EM/IM! Salim Rezaie
June 13, 2013 /

As a senior resident, I was frequently asked to assess the preoperative risk of patients and currently do it on a daily basis as faculty. The goal is to identify procedures and patient factors that could significantly elevate the risk …
Continue reading



June 5, 2013 /

Currently, guidelines advocate for systemic steroid therapy in the management of acute exacerbations of COPD. Multiple randomized clinical trials have shown the benefits on clinical outcomes of COPD (Reduction of LOS and quicker recovery of FEV1). The optimal dose and …
Continue reading



June 1, 2013 /

According to the third report of the National Cholesterol Education Program (NCEP) published in JAMA 2001, blood samples for lipid profiles should be obtained after a 9 – 12 hour fast. It is well known that lipid testing is paramount …
Continue reading



May 24, 2013 /

In medicine, there has been a huge emphasis in preventative care and this mostly occurs in general practice. Cardiovascular disease is the number one killer in the world, and therefore a disease process we should be trying to prevent with …
Continue reading



May 20, 2013 /

In 2011, Azithromycin was the seventh most prescribed (55.3 million prescriptions) medication according to IMS Health. There have been several publications indicating that the use of macrolide antibiotics increase risk of serious ventricular arrhythmias and sudden cardiac death (FDA Adverse …
Continue reading



May 15, 2013 /

Studies show that one in five Medicare beneficiaries returns to the hospital within 30 days of discharge at an annual cost of $18 billion to the program. More importantly, many of these readmissions are thought to be preventable with better …
Continue reading



May 9, 2013 /

Polk HC Jr (1966) and Cornell CM et al (1959) reported the incidence of gallbladder cancer (GBC) to range from 12–62% when porcelain gallbladder (PGB) is seen. The standard for treatment of porcelain gallbladder is prophylactic cholecystectomy. In the past …
Continue reading



May 6, 2013 /

Guidelines for termination of IHCA are generally very vague. It is typically a subjective decision by a physician to terminate efforts. Recently, a very large study was published in the Lancet in October 2012 evaluating this very topic.   What …
Continue reading